- In April 2024, Integra LifeSciences Holdings Corporation (U.S.) acquired Acclarent, Inc. (U.S.), a leader in ENT surgical solutions. This acquisition expands Integra's product portfolio, strengthens its market position, and opens up a growth opportunity worth USD 1 billion in the ENT device sector
- In March 2024, Medical Device Business Services, a subsidiary of Johnson & Johnson (U.S.), partnered with NVIDIA Corporation (U.S.) to enhance real-time analysis and broaden the accessibility of AI algorithms in operating rooms worldwide. This collaboration aims to help surgeons make more informed decisions, improve education, and foster collaboration within connected operating rooms, ultimately improving patient outcomes
- In June 2023, Olympus Corporation introduced the ESG-410 electrosurgical generator, designed to improve treatment efficiencies for benign prostatic hyperplasia (BPH) and non-muscle-invasive bladder cancer (NMIBC). The device offers vaporization buttons, needles, band electrodes, and resection loops for more effective procedures
- In April 2023, Innoblative Designs announced that its SIRA RFA Electrosurgical Device (SIRA) received Breakthrough Device Designation from the U.S. FDA. The device is intended for use in breast cancer patients undergoing breast-conserving surgery
- In November 2023, Erbe Elektromedizin GmbH (Germany) launched the TriSect rapide tool, designed for bipolar coagulation, division, and sealing of vessels and tissue bundles. It also allows for tissue grasping, dissection, and cutting, suitable for open, minimally invasive, and endoscopically assisted procedures across various medical specialties including general visceral surgery, gynecology, urology, pediatrics, and thoracic surgery
